These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 17883389
1. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes. Wang R, Song L, Han G, Wang J, Chen G, Xu R, Yu M, Qian J, Shen B, Li Y. Scand J Immunol; 2007 Nov; 66(5):515-22. PubMed ID: 17883389 [Abstract] [Full Text] [Related]
2. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? Song L, Wang J, Wang R, Yu M, Sun Y, Han G, Li Y, Qian J, Scott DW, Kang Y, Soukhareva N, Shen B. Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360 [Abstract] [Full Text] [Related]
3. The role of STAT3 in antigen-IgG inducing regulatory CD4(+)Foxp3(+)T cells. Wang R, Han G, Wang J, Song L, Chen G, Xu R, Yu M, Qian J, Shen B, Li Y. Cell Immunol; 2007 Apr; 246(2):103-9. PubMed ID: 17697673 [Abstract] [Full Text] [Related]
4. GAD-IgG-inducing CD4+Foxp3+Treg cells suppressing diabetes are involved in the increasing ratio of CD80+:CD86+ CELLS in NOD mice. Wang R, Han G, Wang J, Song L, Chen G, Xu R, Zhang C, Yu M, Qian J, Shen B, Li Y. Arch Med Res; 2008 Apr; 39(3):299-305. PubMed ID: 18279702 [Abstract] [Full Text] [Related]
5. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles. Han G, Wang R, Chen G, Wang J, Xu R, Feng J, Yu M, Wu X, Qian J, Shen B, Li Y. Immunol Lett; 2008 Jan 29; 115(2):110-6. PubMed ID: 18045698 [Abstract] [Full Text] [Related]
6. Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells. Soukhareva N, Jiang Y, Scott DW. Cell Immunol; 2006 Mar 29; 240(1):41-6. PubMed ID: 16860296 [Abstract] [Full Text] [Related]
7. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L. Proc Natl Acad Sci U S A; 2007 Apr 10; 104(15):6335-40. PubMed ID: 17389382 [Abstract] [Full Text] [Related]
8. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro. Li A, Ojogho O, Franco E, Baron P, Iwaki Y, Escher A. Vaccine; 2006 Jun 05; 24(23):5036-46. PubMed ID: 16621191 [Abstract] [Full Text] [Related]
9. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z. Transplantation; 2009 Jan 27; 87(2):198-206. PubMed ID: 19155973 [Abstract] [Full Text] [Related]
10. CD8+ regulatory T cells are responsible for GAD-IgG gene-transferred tolerance induction in NOD mice. Wang R, Han G, Song L, Wang J, Chen G, Xu R, Yu M, Qian J, Shen B, Li Y. Immunology; 2009 Jan 27; 126(1):123-31. PubMed ID: 18624731 [Abstract] [Full Text] [Related]
11. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W. Immunol Lett; 2009 Aug 15; 125(2):105-13. PubMed ID: 19539651 [Abstract] [Full Text] [Related]
12. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase. Jun HS, Chung YH, Han J, Kim A, Yoo SS, Sherwin RS, Yoon JW. Diabetologia; 2002 May 15; 45(5):668-76. PubMed ID: 12107747 [Abstract] [Full Text] [Related]
13. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes. Kishi M, Yasuda H, Abe Y, Sasaki H, Shimizu M, Arai T, Okumachi Y, Moriyama H, Hara K, Yokono K, Nagata M. Biochem Biophys Res Commun; 2010 Mar 26; 394(1):228-32. PubMed ID: 20206130 [Abstract] [Full Text] [Related]
14. Diabetes is not prevented by Foxp3-transduced CD4(+)T cells under the IL-12Rbeta2 promoter control. Wang R, Han G, Wang J, Song L, Chen G, Xu R, Wang L, Li X, Shen B, Li Y. Mol Immunol; 2008 Aug 26; 45(14):3814-7. PubMed ID: 18599122 [Abstract] [Full Text] [Related]
15. Glutamic acid decarboxylase-specific CD4+ regulatory T cells. Liu CP. Ann N Y Acad Sci; 2006 Oct 26; 1079():161-70. PubMed ID: 17130549 [Abstract] [Full Text] [Related]
16. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. Maron R, Melican NS, Weiner HL. J Autoimmun; 1999 Jun 26; 12(4):251-8. PubMed ID: 10330296 [Abstract] [Full Text] [Related]
17. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV. Cell Immunol; 2005 May 26; 235(1):1-11. PubMed ID: 16122720 [Abstract] [Full Text] [Related]
18. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development. Mori Y, Kodaka T, Kato T, Kanagawa EM, Kanagawa O. Int Immunol; 2009 Nov 26; 21(11):1291-9. PubMed ID: 19778991 [Abstract] [Full Text] [Related]
19. [Development of rAAV2-GAD-Ig for IDDM gene therapy]. Wang RX, Wang JA, Song L, Han GC, Shen BF, Wu XB, Li Y. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan 26; 21(1):24-8. PubMed ID: 15629077 [Abstract] [Full Text] [Related]
20. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ. Diabetes; 2007 Aug 26; 56(8):2116-23. PubMed ID: 17496235 [Abstract] [Full Text] [Related] Page: [Next] [New Search]